BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 939462)

  • 1. Purification of canine gut glucagon-like immunoreactivity (GLI) and its insulin releasing activity.
    Ohneda A; Horigome K; Kai Y; Itabashi H; Ishii S; Yamagata S
    Horm Metab Res; 1976 May; 8(3):170-4. PubMed ID: 939462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of extractable gut glucagon-like immunoreactivity (GLI) and its lipolytic activity.
    Horigome K; Oneda A; Maruhama Y; Abe R; Kai Y
    Horm Metab Res; 1977 Sep; 9(5):370-4. PubMed ID: 924346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical biological effects of pancreatic glucagon and a purified moiety of canine gastric immunoreactive glucagon.
    Doi K; Prentki M; Yip C; Muller WA; Jeanrenaud B; Vranic M
    J Clin Invest; 1979 Mar; 63(3):525-31. PubMed ID: 429572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of calcium and other salts upon the release of glucagon-like immunoreactivity from the gut.
    Böttger I; Faloona GR; Unger RH
    J Clin Invest; 1972 Apr; 51(4):831-6. PubMed ID: 5014613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic glucagon-like immunoreactivity in a pancreatectomized patient.
    Botha JL; Vinik AI; Child PT; Paul M; Jackson WP
    Horm Metab Res; 1977 May; 9(3):199-205. PubMed ID: 885471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of response of gut GLI to fat ingestion in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic pattern of gut glucagon-like immunoreactivity (GLI) in plasma before and during glucose absorption.
    Valverde I; Ghiglione M; Matesanz R; Casado S
    Horm Metab Res; 1979 May; 11(5):343-6. PubMed ID: 478429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intraluminal bile or bile acids on release of gut glucagon-like immunoreactive materials in the dog.
    Namba M; Matsuyama T; Nonaka K; Tarui S
    Horm Metab Res; 1983; 15(2):82-4. PubMed ID: 6826142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antilipolytic nature of gut GLI, and mode of action of two highly potent intestinal lipolytic species in birds.
    Krug E
    Horm Metab Res; 1978 Nov; 10(6):505-9. PubMed ID: 217810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anomeric specificity in the response of gut glucagon-like immunoreactive materials to glucose.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Horm Metab Res; 1979 Mar; 11(3):214-6. PubMed ID: 447202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glicentin-related peptides on glucagon secretion in anaesthetized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Diabetologia; 1986 Jun; 29(6):397-401. PubMed ID: 3527839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of glucagon- and GLI-containing cells in the canine gut and pancreas.
    Ito S; Kobayashi S
    Arch Histol Jpn; 1976 Jul; 39(3):193-202. PubMed ID: 788674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional release of glucagon-like immunoreactivity from the intestine of the cat.
    Frame CM
    Horm Metab Res; 1977 Mar; 9(2):117-20. PubMed ID: 863376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific biologic effects of intestinal glucagon-like materials.
    Gutman RA; Fink G; Voyles N; Selawry H; Penhos JC; Lepp A; Recant L
    J Clin Invest; 1973 May; 52(5):1165-75. PubMed ID: 4349485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity.
    Sundby F; Jacobsen H; Moody AJ
    Horm Metab Res; 1976 Sep; 8(5):366-71. PubMed ID: 976935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boiling method for the extraction of gut glucagon-like immunoreactive materials.
    Tanaka R; Shima K; Tarui S; Nishikawa M
    Endocrinol Jpn; 1975 Dec; 22(6):503-7. PubMed ID: 1231992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.